GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Globeimmune GBIM · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 27 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Globeimmune — daily GBIM Delayed
Market value
$575
Last close × shares
Volume
300
Shares, 27 Oct 2026

About Globeimmune

Its shares trade under the ticker GBIM. It has been listed since 2 July 2014. In the fiscal year to 31 December 2015, it reported revenue of $6.5m and a net loss of $2.8m. At that date it held total assets of $11.5m and shareholders' equity of $3.0m.

GlobeImmune, Inc. is a biopharmaceutical company. The company is headquartered in Louisville, Colorado. The company went IPO on 2014-07-02. The firm is focused on developing products for the treatment of cancer and infectious diseases based on its Tarmogen platform. The firm's segment is the business of developing and commercializing various biopharmaceutical products. The firm's infectious disease product candidates include GS-4774, which is in Phase II for the treatment of chronic hepatitis B infection; GI-19000; GI-2010, which is in the preclinical stage of development for the treatment of Human immunodeficiency virus (HIV), and GI-18000, which is in the preclinical stage of development for the treatment of Chronic hepatitis D infection. The firm's oncology product candidates include GI-6207, which is in Phase II for the treatment of medullary thyroid cancer; GI-6301, and GI-4000, which is in Phase IIb for the treatment of Resected pancreas cancer, and in Phase II for the treatment of Non-small cell lung cancer and colorectal cancer.

Figures and description from our data supplier, not checked against the company's own report.

More about Globeimmune →

Latest on Globeimmune

Our reporting

We have not reported on Globeimmune yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Globeimmune's ticker?

Globeimmune trades as GBIM on its US listing, under ISIN US37957B1008.

What was Globeimmune's last closing price?

0.00 on 27 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.